Antimicrobial action of rabbit leukocyte CAP18(106-137).
Abstract
CAP18 is a cationic antimicrobial protein originally isolated from rabbit neutrophils, of which a 32-mer sequence from its C-terminal and (CAP18(106-137)) has been found to be the most active. The bactericidal action of this peptide has been characterized by conventional culture techniques and flow cytometry. Cultures of Escherichia coli NCTC10418 were exposed to the MBC (12 microM) of the peptide for up to 60 min and stained with a fluorochrome sensitive to changes in either membrane potential (bis-(1,3-dibutylbarbituric acid)trimethine oxonol [DiBAC4(3)), or membrane integrity (propidium iodide [PI]) before flow cytometric analysis. Addition of CAP18(106-137) to E. coli in broth culture resulted in immediate collapse of membrane potential [as determined by uptake of DiBAC4(3)] and loss of membrane integrity (as indicated by uptake of PI), with a corresponding 6- to 8-log decrease in viable counts as determined by colony formation on solid media. In identical experiments, the presence of Mg2+ (1 to 10 mM), K+ (50 to 250 mM), or EDTA (5 mM) or incubation in nutrient-free buffer or at 4 degrees C had no effect on peptide-induced dye uptake. In contrast, addition of Ca2+ (1 to 10 mM) or the respiratory chain poison carbonyl cyanide m-chlorophenylhydrazone (CCCP) (50 microM) inhibited the uptake of both dyes. These findings, however, did not relate to bacterial recovery on solid media, where (unless in the presence of K+ 150 to 250 mM) CAP18(106-137) at 12 microM fulfilled the MBC criteria (99.9% killing). We conclude that CAP18(106-137) exerts a rapid and profound action on E. coli cytoplasmic membranes and viability as measured by colony formation. The results suggest, however, that CAP18(106-137) may exert its action at sites additional to the cell membrane and that its activity profile is unique among cationic antimicrobial proteins.
Full Text
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beck WD, Berger-Bächi B, Kayser FH. Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of mec-specific DNA. J Bacteriol. 1986 Feb;165(2):373–378.[PMC free article] [PubMed] [Google Scholar]
- Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol. 1992 Dec;73(6):472–479. [PubMed] [Google Scholar]
- Boman HG, Faye I, Gudmundsson GH, Lee JY, Lidholm DA. Cell-free immunity in Cecropia. A model system for antibacterial proteins. Eur J Biochem. 1991 Oct 1;201(1):23–31. [PubMed] [Google Scholar]
- Chen C, Brock R, Luh F, Chou PJ, Larrick JW, Huang RF, Huang TH. The solution structure of the active domain of CAP18--a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett. 1995 Aug 14;370(1-2):46–52. [PubMed] [Google Scholar]
- Christensen B, Fink J, Merrifield RB, Mauzerall D. Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5072–5076.[PMC free article] [PubMed] [Google Scholar]
- Cruciani RA, Barker JL, Zasloff M, Chen HC, Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3792–3796.[PMC free article] [PubMed] [Google Scholar]
- Duclohier H. Anion pores from magainins and related defensive peptides. Toxicology. 1994 Feb 28;87(1-3):175–188. [PubMed] [Google Scholar]
- Eddy AA. Use of carbocyanine dyes to assay membrane potential of mouse ascites tumor cells. Methods Enzymol. 1989;172:95–101. [PubMed] [Google Scholar]
- Elsbach P, Weiss J. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology. 1993 Apr;187(3-5):417–429. [PubMed] [Google Scholar]
- Gant VA, Warnes G, Phillips I, Savidge GF. The application of flow cytometry to the study of bacterial responses to antibiotics. J Med Microbiol. 1993 Aug;39(2):147–154. [PubMed] [Google Scholar]
- Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985 Oct;76(4):1427–1435.[PMC free article] [PubMed] [Google Scholar]
- Garcerá MJ, Elferink MG, Driessen AJ, Konings WN. In vitro pore-forming activity of the lantibiotic nisin. Role of protonmotive force and lipid composition. Eur J Biochem. 1993 Mar 1;212(2):417–422. [PubMed] [Google Scholar]
- Gustafson C, Tagesson C. Influence of organic solvent mixtures on biological membranes. Br J Ind Med. 1985 Sep;42(9):591–595.[PMC free article] [PubMed] [Google Scholar]
- Jones EM, Smart A, Bloomberg G, Burgess L, Millar MR. Lactoferricin, a new antimicrobial peptide. J Appl Bacteriol. 1994 Aug;77(2):208–214. [PubMed] [Google Scholar]
- Kagan BL, Selsted ME, Ganz T, Lehrer RI. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A. 1990 Jan;87(1):210–214.[PMC free article] [PubMed] [Google Scholar]
- Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun. 1995 Apr;63(4):1291–1297.[PMC free article] [PubMed] [Google Scholar]
- Larrick JW, Hirata M, Shimomoura Y, Yoshida M, Zheng H, Zhong J, Wright SC. Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob Agents Chemother. 1993 Dec;37(12):2534–2539.[PMC free article] [PubMed] [Google Scholar]
- Larrick JW, Hirata M, Zheng H, Zhong J, Bolin D, Cavaillon JM, Warren HS, Wright SC. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol. 1994 Jan 1;152(1):231–240. [PubMed] [Google Scholar]
- Lehrer RI, Ganz T, Szklarek D, Selsted ME. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest. 1988 Jun;81(6):1829–1835.[PMC free article] [PubMed] [Google Scholar]
- Lehrer RI, Szklarek D, Ganz T, Selsted ME. Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun. 1985 Jul;49(1):207–211.[PMC free article] [PubMed] [Google Scholar]
- Mason DJ, Allman R, Stark JM, Lloyd D. Rapid estimation of bacterial antibiotic susceptibility with flow cytometry. J Microsc. 1994 Oct;176(Pt 1):8–16. [PubMed] [Google Scholar]
- Mason DJ, Power EG, Talsania H, Phillips I, Gant VA. Antibacterial action of ciprofloxacin. Antimicrob Agents Chemother. 1995 Dec;39(12):2752–2758.[PMC free article] [PubMed] [Google Scholar]
- Matsuzaki K, Harada M, Funakoshi S, Fujii N, Miyajima K. Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim Biophys Acta. 1991 Mar 18;1063(1):162–170. [PubMed] [Google Scholar]
- Matsuzaki K, Murase O, Tokuda H, Funakoshi S, Fujii N, Miyajima K. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry. 1994 Mar 22;33(11):3342–3349. [PubMed] [Google Scholar]
- Moore RA, Hancock RE. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob Agents Chemother. 1986 Dec;30(6):923–926.[PMC free article] [PubMed] [Google Scholar]
- Nikaido H, Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985 Mar;49(1):1–32.[PMC free article] [PubMed] [Google Scholar]
- Ritonja A, Kopitar M, Jerala R, Turk V. Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett. 1989 Sep 25;255(2):211–214. [PubMed] [Google Scholar]
- Selsted ME, Szklarek D, Ganz T, Lehrer RI. Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun. 1985 Jul;49(1):202–206.[PMC free article] [PubMed] [Google Scholar]
- Tossi A, Scocchi M, Skerlavaj B, Gennaro R. Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett. 1994 Feb 14;339(1-2):108–112. [PubMed] [Google Scholar]
- Tytler EM, Anantharamaiah GM, Walker DE, Mishra VK, Palgunachari MN, Segrest JP. Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry. 1995 Apr 4;34(13):4393–4401. [PubMed] [Google Scholar]
- Urrutia R, Cruciani RA, Barker JL, Kachar B. Spontaneous polymerization of the antibiotic peptide magainin 2. FEBS Lett. 1989 Apr 10;247(1):17–21. [PubMed] [Google Scholar]
- Vaara M. Increased outer membrane resistance to ethylenediaminetetraacetate and cations in novel lipid A mutants. J Bacteriol. 1981 Nov;148(2):426–434.[PMC free article] [PubMed] [Google Scholar]
- Vaara M, Vaara T. Ability of cecropin B to penetrate the enterobacterial outer membrane. Antimicrob Agents Chemother. 1994 Oct;38(10):2498–2501.[PMC free article] [PubMed] [Google Scholar]
- Viljanen P, Vaara M. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Antimicrob Agents Chemother. 1984 Jun;25(6):701–705.[PMC free article] [PubMed] [Google Scholar]
- Waggoner AS. The use of cyanine dyes for the determination of membrane potentials in cells, organelles, and vesicles. Methods Enzymol. 1979;55:689–695. [PubMed] [Google Scholar]
- Wilson HA, Chused TM. Lymphocyte membrane potential and Ca2+-sensitive potassium channels described by oxonol dye fluorescence measurements. J Cell Physiol. 1985 Oct;125(1):72–81. [PubMed] [Google Scholar]
- Yamauchi K, Tomita M, Giehl TJ, Ellison RT., 3rd Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun. 1993 Feb;61(2):719–728.[PMC free article] [PubMed] [Google Scholar]
- Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449–5453.[PMC free article] [PubMed] [Google Scholar]
Abstract
CAP18 is a cationic antimicrobial protein originally isolated from rabbit neutrophils, of which a 32-mer sequence from its C-terminal and (CAP18(106-137)) has been found to be the most active. The bactericidal action of this peptide has been characterized by conventional culture techniques and flow cytometry. Cultures of Escherichia coli NCTC10418 were exposed to the MBC (12 microM) of the peptide for up to 60 min and stained with a fluorochrome sensitive to changes in either membrane potential (bis-(1,3-dibutylbarbituric acid)trimethine oxonol [DiBAC4(3)), or membrane integrity (propidium iodide [PI]) before flow cytometric analysis. Addition of CAP18(106-137) to E. coli in broth culture resulted in immediate collapse of membrane potential [as determined by uptake of DiBAC4(3)] and loss of membrane integrity (as indicated by uptake of PI), with a corresponding 6- to 8-log decrease in viable counts as determined by colony formation on solid media. In identical experiments, the presence of Mg2+ (1 to 10 mM), K+ (50 to 250 mM), or EDTA (5 mM) or incubation in nutrient-free buffer or at 4 degrees C had no effect on peptide-induced dye uptake. In contrast, addition of Ca2+ (1 to 10 mM) or the respiratory chain poison carbonyl cyanide m-chlorophenylhydrazone (CCCP) (50 microM) inhibited the uptake of both dyes. These findings, however, did not relate to bacterial recovery on solid media, where (unless in the presence of K+ 150 to 250 mM) CAP18(106-137) at 12 microM fulfilled the MBC criteria (99.9% killing). We conclude that CAP18(106-137) exerts a rapid and profound action on E. coli cytoplasmic membranes and viability as measured by colony formation. The results suggest, however, that CAP18(106-137) may exert its action at sites additional to the cell membrane and that its activity profile is unique among cationic antimicrobial proteins.